113 related articles for article (PubMed ID: 8276668)
1. A new method for determining dose rate distribution from radioimmuno-therapy using radiochromic media.
Mayer R; Dillehay LE; Shao Y; Song S; Zhang YG; Bartholomew RM; Williams JR
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):505-13. PubMed ID: 8276668
[TBL] [Abstract][Full Text] [Related]
2. Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy.
Mayer R; Dillehay LE; Shao Y; Zhang YG; Song S; Bartholomew RM; Mackenson DG; Williams JR
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):147-57. PubMed ID: 7721611
[TBL] [Abstract][Full Text] [Related]
3. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.
Behr TM; Sharkey RM; Sgouros G; Blumenthal RD; Dunn RM; Kolbert K; Griffiths GL; Siegel JA; Becker WS; Goldenberg DM
Cancer; 1997 Dec; 80(12 Suppl):2591-610. PubMed ID: 9406714
[TBL] [Abstract][Full Text] [Related]
4. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
5. Application of the cross-organ beta dose method for tissue dosimetry in tumor-bearing mice treated with a 90Y-labeled immunoconjugate.
Beatty BG; Kuhn JA; Hui TE; Fisher DR; Williams LE; Beatty JD
Cancer; 1994 Feb; 73(3 Suppl):958-65. PubMed ID: 8306285
[TBL] [Abstract][Full Text] [Related]
6. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
Buchsbaum DJ; Lawrence TS; Roberson PL; Heidorn DB; Ten Haken RK; Steplewski Z
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):629-38. PubMed ID: 8454481
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
[TBL] [Abstract][Full Text] [Related]
9. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy.
Griffith MH; Yorke ED; Wessels BW; DeNardo GL; Neacy WP
J Nucl Med; 1988 Nov; 29(11):1795-809. PubMed ID: 3263479
[TBL] [Abstract][Full Text] [Related]
10. The nonuniformity of antibody distribution in the kidney and its influence on dosimetry.
Flynn AA; Pedley RB; Green AJ; Dearling JL; El-Emir E; Boxer GM; Boden R; Begent RH
Radiat Res; 2003 Feb; 159(2):182-9. PubMed ID: 12537523
[TBL] [Abstract][Full Text] [Related]
11. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dosimetry procedures and assessment for EBT2 radiochromic film.
Mayer RR; Ma F; Chen Y; Miller RI; Belard A; McDonough J; O'Connell JJ
Med Phys; 2012 Apr; 39(4):2147-55. PubMed ID: 22482635
[TBL] [Abstract][Full Text] [Related]
13. Use of bremsstrahlung radiation to monitor Y-90 tumor and whole body activities during experimental radioimmunotherapy in mice.
Dillehay LE; Mayer R; Zhang YG; Song SY; Shao Y; Mackensen DG; Williams JR
Cancer; 1994 Feb; 73(3 Suppl):945-50. PubMed ID: 8306283
[TBL] [Abstract][Full Text] [Related]
14. Prediction of tumor response to experimental radioimmunotherapy with 90Y in nude mice.
Dillehay LE; Mayer R; Zhang YG; Shao Y; Song SY; Mackensen DG; Williams JR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):417-27. PubMed ID: 7673029
[TBL] [Abstract][Full Text] [Related]
15. Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.
Breitz HB; Fisher DR; Goris ML; Knox S; Ratliff B; Murtha AD; Weiden PL
Cancer Biother Radiopharm; 1999 Oct; 14(5):381-95. PubMed ID: 10850323
[TBL] [Abstract][Full Text] [Related]
16. A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography.
Muthuswamy MS; Roberson PL; Ten Haken RK; Buchsbaum DJ
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):165-72. PubMed ID: 8641915
[TBL] [Abstract][Full Text] [Related]
17. Multichannel film dosimetry with nonuniformity correction.
Micke A; Lewis DF; Yu X
Med Phys; 2011 May; 38(5):2523-34. PubMed ID: 21776787
[TBL] [Abstract][Full Text] [Related]
18. Radiation dosimetry for radioimmunotherapy. An overview of current capabilities and limitations.
Fisher DR
Cancer; 1994 Feb; 73(3 Suppl):905-11. PubMed ID: 8306278
[TBL] [Abstract][Full Text] [Related]
19. Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Bhatia J; Morris R; Begent RH
Int J Radiat Biol; 2002 May; 78(5):407-15. PubMed ID: 12020430
[TBL] [Abstract][Full Text] [Related]
20. Comparison of methods for the measurement of radiation dose distributions in high dose rate (HDR) brachytherapy: Ge-doped optical fiber, EBT3 Gafchromic film, and PRESAGE® radiochromic plastic.
Palmer AL; Di Pietro P; Alobaidli S; Issa F; Doran S; Bradley D; Nisbet A
Med Phys; 2013 Jun; 40(6):061707. PubMed ID: 23718586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
